Source: U..S. Customs and Border Patrol
June 6, 2020 (Washington D.C.) -- U.S. Customs and Border Protection (CBP) continues to identify and seize a large number of counterfeit, unapproved or otherwise substandard COVID-19 products that threaten the health and safety of American consumers.
As of June 1, CBP had seized more than:
- 107,300 FDA-prohibited COVID-19 test kits in 301 incidents;
- 750,000 counterfeit face masks in 86 incidents;
- 2,500 EPA-prohibited anti-virus lanyards in 89 incidents; and
- 11,000 FDA-prohibited chloroquine tablets in 91 incidents.
Recent comments